Publication: Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A
Loading...
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Attarian, S., J. Vallat, L. Magy, B. Funalot, P. Gonnaud, A. Lacour, Y. Péréon, et al. 2016. “Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.” Orphanet Journal of Rare Diseases 11 (1): 92. doi:10.1186/s13023-016-0463-6. http://dx.doi.org/10.1186/s13023-016-0463-6.
Abstract
Description
Other Available Sources
Research Data
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service